Skip to main content
Livermore
Livermore
ZHEN

First Turn Management, LLC

SEC CIK
0001993440
Latest filing
Aug 14, 2026

Holdings in Q4 2024

Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only; changes compare share counts with Q3 2024.

Institution overview
Positions
36
−2 vs. Q3 2024
Portfolio value
$558.3M
−$73.3M (−11.6%) vs. Q3 2024
Filed
Feb 14, 2025
SEC
Holdings of First Turn Management, LLC in Q4 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
PRAXPraxis Precision Medicines, Inc.COM NEW45,536$3.50M0.6%+45,536NewHistory
SNDXSyndax Pharmaceuticals IncCOM441,587$5.84M1.0%−745,578−62.8%ReducedHistory
BPMCBlueprint Medicines CorpCOM67,143$5.86M1.0%−111,786−62.5%ReducedHistory
BCAXBicara Therapeutics Inc.COM346,170$6.03M1.1%−216,221−38.4%ReducedHistory
SPRYARS Pharmaceuticals, Inc.COM593,291$6.26M1.1%00.0%UnchangedHistory
CRMDCorMedix Inc.COM1,021,421$8.27M1.5%+1,021,421NewHistory
BHVNBiohaven Ltd.COM262,442$9.80M1.8%−53,374−16.9%ReducedHistory
HROWHarrow, Inc.COM304,874$10.2M1.8%−21,708−6.6%ReducedHistory
APGEApogee Therapeutics, Inc.COM252,725$11.4M2.1%+252,725NewHistory
ACLXArcellx, Inc.COMMON STOCK152,356$11.7M2.1%−61,942−28.9%ReducedHistory
ORICOric Pharmaceuticals, Inc.COM1,451,037$11.7M2.1%00.0%UnchangedHistory
ADMAAdma Biologics, Inc.COM684,230$11.7M2.1%+19,245+2.9%AddedHistory
MRUSMerus N.V.COM285,159$12.0M2.1%−22,855−7.4%ReducedHistory
DAWNDay One Biopharmaceuticals, Inc.Stock947,878$12.0M2.2%00.0%UnchangedHistory
ELVNEnliven Therapeutics, Inc.COM535,092$12.0M2.2%00.0%UnchangedHistory
HQYHealthequity, Inc.COM125,867$12.1M2.2%+125,867NewHistory
ASNDAscendis Pharma A/SSPONSORED ADR87,804$12.1M2.2%−62,789−41.7%ReducedHistory
BBIOBridgeBio Pharma, Inc.COM452,290$12.4M2.2%+52,509+13.1%AddedHistory
GERNGeron CorpCOM3,893,327$13.8M2.5%+768,360+24.6%AddedHistory
GKOSGLAUKOS CorpCOM96,097$14.4M2.6%00.0%UnchangedHistory
NTRANatera, Inc.COM99,159$15.7M2.8%−56,491−36.3%ReducedHistory
AXSMAxsome Therapeutics, Inc.COM192,146$16.3M2.9%−63,148−24.7%ReducedHistory
EXASExact Sciences CorpCOM309,890$17.4M3.1%+309,890NewHistory
RVMDRevolution Medicines, Inc.COM403,915$17.7M3.2%+403,915NewHistory
ISRGIntuitive Surgical IncCOM NEW35,032$18.3M3.3%+4,778+15.8%AddedHistory
VERAVera Therapeutics, Inc.CL A464,807$19.7M3.5%+138,313+42.4%AddedHistory
JANXJanux Therapeutics, Inc.COM383,602$20.5M3.7%+383,602NewHistory
MIRMMirum Pharmaceuticals, Inc.COM506,908$21.0M3.8%−140,703−21.7%ReducedHistory
PCVXVaxcyte, Inc.COM276,905$22.7M4.1%+64,920+30.6%AddedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM453,376$23.2M4.2%+100,000+28.3%AddedHistory
NUVLNuvalent, Inc.COM309,521$24.2M4.3%−49,593−13.8%ReducedHistory
ITCIIntra-Cellular Therapies, Inc.COM294,414$24.6M4.4%+39,614+15.5%AddedHistory
ARGXArgenx SESPONSORED ADR43,078$26.5M4.7%−11,362−20.9%ReducedHistory
XENEXenon Pharmaceuticals Inc.COM684,986$26.9M4.8%+359,768+110.6%AddedHistory
VRNAVerona Pharma plcSPONSORED ADS641,901$29.8M5.3%+68,973+12.0%AddedHistory
INSMINSMED IncCOM PAR $.01446,980$30.9M5.5%+90,529+25.4%AddedHistory

Sold out since Q3 2024 (9)

Positions held at the end of Q3 2024 that are gone from this filing.

Positions of First Turn Management, LLC sold out since Q3 2024
SecurityClassShares in Q3 2024Value in Q3 2024% of portfolio in Q3 2024History
TMDXTransMedics Group, Inc.COM114,247$17.9M2.8%History
VRTXVertex Pharmaceuticals IncStock35,222$16.4M2.6%History
ESTAEstablishment Labs Holdings Inc.COM357,003$15.4M2.4%History
RGENRepligen CorpCOM88,714$13.2M2.1%History
KRYSKrystal Biotech, Inc.COM67,942$12.4M2.0%History
CYTKCytokinetics IncCOM NEW223,147$11.8M1.9%History
RCKTRocket Pharmaceuticals, Inc.COM621,306$11.5M1.8%History
RLAYRelay Therapeutics, Inc.COM1,226,354$8.68M1.4%History
KALVKalVista Pharmaceuticals, Inc.COM355,000$4.11M0.7%History